Rachana Gupta co-founded Gynoveda to treat PCOS and period disorders with Ayurveda, not painkillers

Millions of Indian women live with irregular, painful or missing periods, with PCOS, with the long tail of hormonal problems that sit underneath so much of women’s health. The usual script is grim: a painkiller for the cramps, hormonal pills that mask the symptom without touching the cause, and a doctor’s visit most women put off for years because the whole subject is wrapped in shame. Rachana Gupta lived that script herself, and eventually decided to rewrite it.

She co-founded Gynoveda in 2019 in Mumbai, and she did not do it alone. Her partners were Dr. Aarati Patil, an Ayurvedic gynaecologist who had spent more than a decade treating exactly these conditions, and Vishal Gupta, Rachana’s husband, who had run large consumer businesses. Between a marketer who understood the shame, a doctor who understood the medicine, and an operator who understood scale, they built what they call an Ayurveda femtech brand. This is the founder story behind it.

Early life and education

Rachana has kept the private details of her early life out of the press, and there is no reliable public record of her birth year, so this piece will not invent one. Her career, though, is a matter of record, and it is not the one you would predict for someone who ended up running a women’s health company built on Ayurveda.

She spent roughly seventeen years in the business-process-outsourcing world, leading operations, training and development at large BPO firms. That is a career about running big teams and tight processes at scale, worlds away from menstrual health. She has also written a book, on the pursuit of happiness, which tells you something about the person: someone already inclined to think about wellbeing, not just throughput.

Career before Gynoveda, and the doctor who made it credible

Rachana’s operating background matters, but Gynoveda would not exist, or would not be trusted, without her co-founder Dr. Aarati Patil. Aarati is an Ayurvedic gynaecologist and fertility specialist with a Doctor of Medicine in Ayurveda and, by the company’s account, over fifteen years of clinical experience and tens of thousands of patients treated. She leads the research and the formulations. She is the reason the brand can claim to be treating a condition rather than selling a supplement.

The third co-founder, Vishal Gupta, is Rachana’s husband and the company’s chief executive. He had been a vice president at the travel company Cleartrip and a business head at Jio, so he arrived with the scaling and consumer-internet experience the other two did not have. It is a genuinely complementary trio: brand and community, clinical depth, and commercial scale. The two women built the parts that make Gynoveda what it is, the trust and the treatment.

Why they started Gynoveda

The insight came from Rachana’s own body and a gap she could not un-see. Modern medicine, for a huge range of menstrual and hormonal problems, tends to either suppress the symptom or reach for hormonal drugs, and a lot of women drop out of treatment because it does not feel like it is fixing anything. Ayurveda, meanwhile, has a deep tradition of treating exactly these conditions, but it sat trapped in an old-fashioned, unmeasured, hard-to-trust format: a practitioner, a set of powders, and no data.

Gynoveda’s bet was that the tradition was valuable and the packaging was broken. If you could take genuine Ayurvedic treatment and wrap it in the things modern consumers expect, a diagnostic to tell you what is actually wrong, a clear protocol, tracking to show whether it is working, and a community so no one feels alone with it, you could get women to start and, harder still, to stay. That combination of ancient medicine and modern product is the whole company.

The product: a period test, a protocol, and a community

Gynoveda’s starting point is a diagnostic, a period test that maps a woman’s symptoms to an Ayurvedic assessment and points to a specific treatment, rather than a generic one-size supplement. From there it sells Ayurvedic formulations designed for particular conditions, PCOS, irregular or painful periods, fertility support, menopause, backed by the company’s own clinical research and published studies.

Around the pills sits the part that actually drives results: content that explains, in plain language, what is happening in a woman’s body, and a community of other women going through the same thing. Chronic conditions are won or lost on adherence, on whether someone keeps taking the treatment for the months it needs to work. A brand that teaches and supports, rather than just ships bottles, is playing the adherence game, and in women’s health that is the game that counts.

The early struggle

Two big walls stood in the way. The first is stigma. Menstrual and reproductive health is still spoken about in whispers in much of India, which makes acquiring customers, and getting them to talk honestly about symptoms, genuinely hard. Gynoveda’s heavy investment in content and community is partly a response to that: you have to normalise the conversation before you can sell the cure.

The second is credibility. Ayurveda’s market is crowded with vague claims and me-too herbal products, and a serious brand has to work hard to stand apart from it. Gynoveda’s answer was to lead with a doctor, run clinical studies and publish them, and tie its formulations to a diagnostic. That is slower and more expensive than slapping "natural" on a label, and it is the moat. Building trust in a category full of overclaiming is the hardest and most valuable thing the company has done.

Funding and revenue

Fireside Ventures backed Gynoveda early, putting in about a million dollars around 2019, a consumer-brand specialist betting on the founders before there was much to see. The company then raised a Series A of about 10 million dollars in March 2023, led by India Alternatives Fund, with Wipro Enterprises, RPG Ventures, the DS Group and the venture-debt firm Alteria Capital joining alongside Fireside. Total disclosed funding is in the region of 11 million dollars, which is measured rather than enormous, and appropriate for a brand building trust slowly.

On the business itself, the company has said it reached an annual revenue run rate of around 100 crore rupees within roughly three years of starting, and that its period test and formulations have reached more than two lakh women. Those are company figures rather than audited accounts, so treat them as the company’s own claims, but they point to real traction in a category most investors had ignored.

Rachana Gupta’s net worth and what she owns

There is no verified public net-worth figure for Rachana Gupta, and any number attached to her name online has been invented. Gynoveda is a private company that has raised around 11 million dollars and has not disclosed a founder shareholding, so there is no valuation or stake anyone outside the company can turn into a personal figure.

The sensible way to think about it: she is one of three co-founders of a venture-backed brand that is growing but still early, which means a real, illiquid and unpriced stake whose worth depends entirely on where Gynoveda goes from here. A number would be a guess. Treat any specific figure you see online as fabricated.

Growth strategy: three choices that did the work

The first was to lead with a diagnostic rather than a product. Starting with a period test reframes the whole transaction: the customer is not buying a hopeful supplement, she is getting an assessment and then a treatment matched to it. That earns trust and it improves outcomes, which in a treatment brand is the same thing.

The second was to make the medicine measurable. Ayurveda’s weakness in the modern market is that it is hard to trust, so Gynoveda leaned into clinical studies, published evidence and a qualified doctor at the centre of the brand. That is the opposite of how most Ayurvedic products are sold, and it is exactly why this one can charge for a course of treatment rather than a jar of powder.

The third was to treat community as core infrastructure, not marketing. Because these conditions are chronic and stigmatised, women need to feel understood and to stay the course for months. The content and the community are what convert a first purchase into a completed treatment, which is where the real value, medical and commercial, is created.

What Gynoveda’s story teaches Indian founders

The first lesson is that an old thing in a broken format can be a huge opportunity. Ayurveda was not the innovation; making it measurable, trustworthy and easy to stick to was. Some of the best businesses do not invent a new product at all. They take something that already works and fix everything around it that stops people using it.

The second is about the shape of a founding team. Gynoveda pairs a marketer who understood the customer’s shame with a doctor who understood the medicine. Neither could have built this alone; the brand needs both the trust and the treatment, and they came from different people. Founders often look for co-founders who are like them. The more useful search is for the person who holds the half of the problem you cannot.

The third is that in health, credibility is the strategy. It would have been faster to sell vague herbal wellness. Choosing instead to run studies, publish them and put a qualified physician at the core is slower and dearer, and it is the only thing that lets a brand in a crowded, over-claiming category be believed. In women’s health especially, being trusted is the whole business.

Frequently asked questions about Rachana Gupta and Gynoveda

Who is Rachana Gupta?

Rachana Gupta is a co-founder of Gynoveda, an Ayurveda femtech brand for women’s menstrual and reproductive health that she started in Mumbai in 2019. She spent around 17 years in BPO operations and training before founding the company, and leads its brand and community. She co-founded Gynoveda with the Ayurvedic gynaecologist Dr. Aarati Patil and with her husband Vishal Gupta.

Who are Gynoveda’s co-founders?

Three people. Rachana Gupta (brand and community) and Dr. Aarati Patil, an Ayurvedic gynaecologist and fertility specialist who leads research and formulations, are the two women co-founders. Vishal Gupta, Rachana’s husband and the company’s CEO, previously worked at Cleartrip and Jio.

What is Rachana Gupta’s net worth?

There is no verified public net-worth figure. Gynoveda is private, has raised about $11 million, and has not disclosed a founder shareholding, so any specific figure online is fabricated. Her stake is real but illiquid and unpriced.

What does Gynoveda do?

Gynoveda is an Ayurveda femtech brand for women’s health, focused on menstrual and reproductive conditions like PCOS, irregular or painful periods, fertility and menopause. It starts with an Ayurvedic period test, then offers condition-specific formulations backed by its own clinical research, wrapped in content and a community to help women stick with treatment.

How much funding has Gynoveda raised?

About $11 million in total. Fireside Ventures put in roughly $1 million around 2019, and Gynoveda raised a $10 million Series A in March 2023 led by India Alternatives Fund, with Wipro Enterprises, RPG Ventures, the DS Group and Alteria Capital participating.

What can founders learn from Gynoveda?

Two things. A traditional product in a broken format can be a big opportunity: Gynoveda’s innovation was making Ayurveda measurable and trustworthy, not inventing it. And in health, credibility is the strategy, which is why leading with a doctor and published studies beats vague wellness claims.